Share Prices & Company Research

Stockbroking

Immunodiagnostic Systems Holdings

Current Price 205.00p Bid 190.00p Ask 220.00p Change 0.00%
Last Updated: 02/04/2020 16:13. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Financial Highlights Year Ended 31/03/2019

Revenue
£38.51m
Operating Profit/Loss
£0.43m
Dividend yield (%)
0.40
Total dividend for year
0.7000p
Dividend cover
3.43
P/E Ratio
72.90

Key Personnel

Jaap Stuut
Chief Executive Officer

Stock Details

EPIC
IDH
ISIN
GB00B01YZ052
Shares in Issue
28.78m
Market cap
£59.01m
Sector

Analyst Views (0)

Strong Buy
 
0%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
205.00p
Bid Price
190.00p
Ask Price
220.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
205.00p
Previous Close
205.00p
Intraday High
205.00p
Intraday Low
205.00p
52 Week High
290.00p
52 Week Low
170.00p
52 week high and low figures quoted above are calculated from intraday price data.

Immunodiagnostic Systems Holdings News

Earnings suffer in year of change for Immunodiagnostic Systems 20 Jun 2018 | 11:03 Omega Diagnostics inks distribution agreement with IDS 20 Apr 2018 | 09:12 Immunodiagnostic Systems Holdings appoints new CEO 19 Jan 2017 | 17:31 Immunodiagnostic Systems expects stable revenues 21 Oct 2016 | 12:34 Immunodiagnostic revenues shrink as clients move on 22 Jun 2016 | 16:33 Immunodiagnostic launches first product in fertility portfolio 06 May 2016 | 12:42 Immunodiagnostic Systems warns of revenue decline 25 Apr 2016 | 10:25 Immundiagnostic Systems sales slide in first quarter 04 Aug 2015 | 11:12 Immunodiagnostic Systems confirms CFO departure 29 Jun 2015 | 07:46 Results Round-up 23 Jun 2015 | 15:00 Immunodiagnostic Systems says 2015 was not a successful year 23 Jun 2015 | 11:32 Immundiagnostic Systems plunges on revenue warning 29 May 2015 | 10:08 Immunodiagnostic Systems chairman follows CEO and resigns 25 Nov 2014 | 13:10 Tuesday broker round-up UPDATE 14 Oct 2014 | 12:54 Immunodiagnostics warns revenues will miss expectations 15 Sep 2014 | 15:40 Thursday broker round-up UPDATE 21 Aug 2014 | 12:58 Tuesday broker round-up UPDATE 12 Aug 2014 | 13:59 Wednesday broker round-up UPDATE 23 Jul 2014 | 13:50 Immunodiagnostic ups dividend and unveils bullish five-year plan 24 Jun 2014 | 12:00 Thursday broker round-up UPDATE 19 Jun 2014 | 12:00 Sector movers: Healthcare stocks rise as M&A fever continues 24 Apr 2014 | 16:05 Immunodiagnostics Systems in line but placements disappoint 15 Apr 2014 | 14:09 Sector movers: Mobile telecoms, healthcare stocks rise as results impress 06 Feb 2014 | 14:37 Wednesday broker round-up UPDATE 27 Nov 2013 | 12:58 Monday broker round-up UPDATE 25 Nov 2013 | 11:06

Income Statement

Year End Date
31 Mar 2019
31 Mar 2018
 
£ (M)
£ (M)
Continuing Operations
Revenue
38.51
37.95
Operating Profit/Loss
0.43
0.95
Net Interest
-0.41
-0.01
Pre-Tax Profit
0.84
0.94
Profit After Tax from continuing operations
0.80
1.23
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
0.80
1.23
Attributable to:
Equity Holders of Parent Company
0.80
1.23
Minority Interests
n/a
n/a
Total Dividend Paid
0.7000p
1.7000p
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Mar 2019
31 Mar 2018
Basic
2.70p
4.20p
Diluted
2.70p
4.20p
Adjusted
2.40p
5.70p
Dividend per Share
0.7000p
1.7000p

Assets

Year End Date
31 Mar 2019
31 Mar 2018
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
6.85
7.47
Intangible Assets
11.18
10.99
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
0.35
0.73
Current Assets
Inventories
7.82
8.38
Trade & Other Receivables
11.63
11.07
Cash at Bank & In Hand
27.71
28.53
Current Asset Investments
n/a
n/a
Other Current Assets
0.38
0.37
Other Assets
n/a
n/a
Total Assets
65.92
67.54

Liabilities

Year End Date
31 Mar 2019
31 Mar 2018
 
£ (M)
£ (M)
Current Liabilities
Borrowings
0.08
0.08
Other Current Liabilities
7.24
7.18
Total Current Liabilities
7.32
7.26
Non-Current Liabilities
Borrowings
1.09
1.20
Provisions
1.84
1.85
Other Non-Current Liabilities
0.36
0.36
Total Non-Current Liabilities
3.30
3.40
Other Liabilities
n/a
n/a
Total Liabilities
10.62
10.67

Net Assets

Year End Date
31 Mar 2019
31 Mar 2018
 
£ (M)
£ (M)
Net Assets
55.30
56.87

Capital & Reserves

Year End Date
31 Mar 2019
31 Mar 2018
 
£ (M)
£ (M)
Share Capital
0.59
0.59
Share Premium Account
32.34
32.34
Other Reserves
4.66
5.17
Retained Earnings
17.71
18.77
Shareholders Funds
55.30
56.87
Minority Interests/Other Equity
n/a
n/a
Total Equity
55.30
56.87

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Final
18 Jul 2019
16 Aug 2019
0.70p
Final
19 Jul 2018
17 Aug 2018
1.70p
Final
20 Jul 2017
18 Aug 2017
4.00p
Final
21 Jul 2016
19 Aug 2016
1.20p
Final
24 Jul 2013
23 Aug 2013
3.00p

Dividend Metrics

Year End Date
31 Mar 2019
31 Mar 2018
Dividend growth
-58.82%
-57.50%
Dividend yield
0.40%
0.80%
Dividend cover
3.43
3.35
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 26th March 2020
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.